Work at Home in the Health and Wellness Industry

From Aloe Vera to Acemannan

In the early ’90s, there was a group of research pharmacologists that looked at the Aloe Vera plant and they knew that in fresh Aloe Vera there was something that caused a very profound immune response that was unseen in modern medicine.

A public pharmaceutical company was created because of the discovery they had made. It was called Carrington Laboratories.

The problem with the Aloe Vera plant was it was labile. You could take the fresh gel and put it in a petri dish of cell cultures and you could see this incredible response, however, the next day it was completely gone – so whatever it was it was denatured and been made labile in 24 hours.

So they hired a group of pharmacologist from the South Western Medical school to identify what the molecular structure is that was causing this because they didn’t know what to stabilise until they knew the molecule that was causing this effect.

They discovered that it was a long chain polysaccharide (many sugars).

Unlike any sugar that we are used to seeing like sucrose – this is a sugar that is absolutely essential in human physiology and it’s necessary for the proper structure and function of every cell in the body, but it is absolutely essential for the proper functioning of the immune system.

So, they discovered it was a polysaccharide – that was pretty radical as the only thing known about sugar in those days in biochemistry was that it contributed to the conversion of ATP in the body and produced energy – nobody had ever heard of a therapeutic sugar. This was one.

Carrington Laboratories spent over $100 million of their public offering on validating the mechanism of action of the polysaccharide in human physiology and their goal was to bring it to the market as a drug.

They also filed and received over 130 patents worldwide on this discovery and its stabilisation process.

They called this molecule Acemannan – an abbreviation of its chemical structure – its’ a beta 1, 4 linked acetylated polymannans – shortened to Acemannan.

This technology was approved by the USDA – United States Department of Agriculture – which manages the development of drugs that can be used in the Agriculture industry.

They had shown that this Acemannan technology was effective in the treatment of all types of cancer in all types of animals.

It doesn’t attack cancer – it enhances the immune systems ability to recognise and kill cancer. So, they got a drug approved – the first injectable immuno-stimulant that was non-toxic ever in the USDA history.

They then went to the FDA thinking we’ve already crossed the USDA bridge so the next would be easy to accomplish.

The problem with the FDA is that they have a set of rules that have been developed by Big Pharma.

There are 2 things.

1. You have to prove the toxicity level of your drug – if it is non-toxic, it doesn’t qualify as a drug
2. You have to alter physiology with the drug – either the physiology of the disease process or human physiology in the way that it deals with it

So, nutrition supports physiology – drugs alter physiology. Acemannan didn’t alter physiology – it enhances physiology and because of this – it was turned down as a drug and the journey of bringing Acemannan to the market place began with distribution via Mannatech, a multi-level marketing company.

From Acemannan to Acemannan AE™

In 2014, Dr Santiago Rodriguez, the worlds leading expert on Acemannan technologies used new science to develop a second-generation Acemmanan extract with 4-5 times more immune-activating fractions per gram than his original patented product.

This new extract was named Alovéa AE (Acemannan Extract) and was donated exclusively to the HOPE Movement to support their Social Business platform for global health transformation.